AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ATRC · NASDAQ · Medical - Instruments & Supplies

AtriCure (ATRC)

Makes surgical cardiac ablation, AtriClip appendage exclusion, and cryo nerve block devices.

$53.00

Pre-market+0.38 (+0.72%)

At close$52.62(+7.56%)

Watchlist

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	98	107	109	116	116	124	124	136	134	141	141	154
Cost of revenue	24	27	28	30	29	32	31	35	33	36	32	35
Gross profit	74	79	81	86	87	93	93	101	101	105	109	119
	82	88	91	93	94	107	99	108	101	101	109	109
Research & development	20	21	20	20	21	35	23	29	23	23	24	26
Selling, general & administrative	62	67	72	74	73	72	76	78	78	78	85	83
Operating income	−8	−9	−11	−7	−7	−15	−6	−6	0	3	1	10
	−1	−1	−2	−1	0	−1	−1	0	0	−1	0	0
Interest income	1	1	1	1	1	1	1	1	2	1	1	1
Interest expense	2	2	2	2	2	1	1	1	3	2	1	1
Other non-operating income	−1	−1	0	−1	−2	−1	−1	−2	−3	0	−1	1
Income before tax	−9	−9	−13	−8	−8	−15	−7	−6	0	2	0	9
Income tax expense	0	0	0	0	0	0	0	0	0	1	0	0
Net income from continuing operations	−9	−10	−13	−8	−8	−16	−7	−6	0	2	0	9
Net income	−9	−10	−13	−8	−8	−16	−7	−6	0	2	0	9
EPS, basic	−$0.20	−$0.21	−$0.28	−$0.17	−$0.17	−$0.33	−$0.14	−$0.13	−$0.01	$0.04	$0.00	$0.18
EPS, diluted	−$0.20	−$0.21	−$0.28	−$0.17	−$0.17	−$0.33	−$0.14	−$0.13	−$0.01	$0.04	$0.00	$0.18
Weighted average shares, basic	46	46	47	47	47	47	47	48	48	48	48	49
Weighted average shares, diluted	46	46	47	47	47	47	47	48	48	49	49	49
EBITDA	−3	−3	−7	−2	−1	−9	0	1	8	9	7	3
Depreciation & amortization	4	4	4	5	5	5	5	5	5	5	5	−5
EBIT	−7	−8	−11	−6	−6	−14	−5	−4	3	4	2	8